Designing inhaled protein therapeutics for topical lung delivery: what are the next steps?

Expert Opin Drug Deliv. 2018 Aug;15(8):729-736. doi: 10.1080/17425247.2018.1503251. Epub 2018 Jul 27.

Authors

Elsa Bodier-Montagutelli^{1

2

3}, Alexie Mayor^{1

2

4}, Laurent Vecellio^{1

2}, Renaud Respaud^{1

2

3}, Nathalie Heuzé-Vourc'h^{1

2}

Affiliations

¹ a Centre d'Etude des Pathologies Respiratoires , Université de Tours , Tours , France.
² b Centre d'Etude des Pathologies Respiratoires, U1100 , INSERM, Centre d'Etude des Pathologies Respiratoires , Tours , France.
³ c CHRU de Tours , Service de Pharmacie , Tours , France.
⁴ d Formulation Development Unit - Biotherapeutics , Sanofi Aventis Recherche Développement , Vitry-sur-Seine , France.

PMID: 30025210
DOI: 10.1080/17425247.2018.1503251

No abstract available

Keywords: Inhalation; aerosol therapy; formulation; nebulizers; protein therapeutics.

Publication types

Editorial